Hypothesis

Morning bright light (≥3000 lux, 30 min) increases the proportion of slow‑wave sleep (SWS) the following night, but only in individuals with high melanopsin‑mediated ipRGC sensitivity. The effect is mediated by a light‑driven rise in PER1 expression in the suprachiasmatic nucleus that augments GABAergic output to the ventrolateral preoptic nucleus, thereby deepening NREM sleep.

Mechanistic Rationale

1. Light activates melanopsin‑containing ipRGCs → retinohypothalamic tract → SCN.
2. In the SCN, light triggers PER1 overexpression during the late subjective night, shifting the clock phase (3).
3. PER1 peaks enhance the transcriptional drive of GABA‑synthesizing enzymes in SCN neurons that project to the VLPO, a key sleep‑promoting area.
4. Elevated VLPO GABA release suppresses arousal nuclei (LC, TMN) during sleep, reducing cortical arousal and allowing longer, more stable SWS episodes.
5. Individuals with greater ipRGC melanopsin density exhibit larger PER1 induction for a given photon flux, producing a stronger GABAergic tone and thus a larger SWS gain.
6. Conversely, low‑sensitivity subjects show minimal PER1 change, so their SWS remains unaffected or may even decline due to compensatory homeostatic processes.

Testable Predictions

• Prediction 1: Participants stratified by high vs low pupil constriction response to 480 nm light (a proxy for melanopsin sensitivity) will show a significant interaction: high‑sensitivity group gains ≥10 % SWS after morning bright light, while low‑sensitivity group shows ≤2 % change.
• Prediction 2: Pharmacological blockade of SCN‑VLPO GABA transmission (e.g., local bicuculline microinjection in animal models) will abolish the SWS increase despite identical light exposure.
• Prediction 3: PER1 mRNA levels measured in peripheral blood mononuclear cells (as a surrogate for SCN activity) will correlate positively with the magnitude of SWS gain across subjects (r > 0.4, p < 0.05).

Experimental Design

• Recruit 60 healthy adults, screen for ipRGC sensitivity via infrared pupillometry.

• Randomize within each sensitivity stratum to either Bright Light (10 000 lux, blue‑enriched, 30 min, 07:00–07:30) or Dim Light (<50 lux, same timing) for five consecutive days.

• Each night, record polysomnography; quantify SWS (% of total sleep time) and REM (%).

• Analyze with a mixed‑effects model: fixed effects = Light condition, Sensitivity stratum, interaction; random intercept = subject.

Falsifiability

If the interaction term is non‑significant (p > 0.1) and the bright‑light condition does not produce a greater SWS increase in the high‑sensitivity group relative to dim light, the hypothesis is falsified. Similarly, if PER1 surrogate levels fail to correlate with SWS changes, the proposed mechanistic link is undermined.

By tying individual ipRGC phenotype to a concrete downstream sleep architecture outcome, this hypothesis bridges the circadian entrainment gap identified in the literature and offers a clear, falsifiable pathway for future translational work.